Dew--Are there other companies out there that are pursuing alternative ways to restore p53 function? I seem to recall several big pharma groups (Pfizer?, Roche?) looking at small molecules that potentiate the growth inhibitory effect of p53. I think the idea is to modulate proteins that promote p53 degradation (e.g. MDM2) and restore mutant p53 function. Not sure if any of these are in clinical trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.